These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26557755)

  • 1. Statins and cancers.
    Stryjkowska-Góra A; Karczmarek-Borowska B; Góra T; Krawczak K
    Contemp Oncol (Pozn); 2015; 19(3):167-75. PubMed ID: 26557755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins in risk-reduction and treatment of cancer.
    Barbalata CI; Tefas LR; Achim M; Tomuta I; Porfire AS
    World J Clin Oncol; 2020 Aug; 11(8):573-588. PubMed ID: 32879845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and cancer.
    Vallianou NG; Kostantinou A; Kougias M; Kazazis C
    Anticancer Agents Med Chem; 2014 Jun; 14(5):706-12. PubMed ID: 24295174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
    Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
    Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and protein prenylation in cancer cell biology and therapy.
    Garcia-Ruiz C; Morales A; Fernandez-Checa JC
    Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins: perspectives in cancer therapeutics.
    Corcos L; Le Jossic-Corcos C
    Dig Liver Dis; 2013 Oct; 45(10):795-802. PubMed ID: 23490341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M; Rollini M
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
    Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
    Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.
    Chimento A; Casaburi I; Avena P; Trotta F; De Luca A; Rago V; Pezzi V; Sirianni R
    Front Endocrinol (Lausanne); 2018; 9():807. PubMed ID: 30719023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and prostate cancer: molecular and clinical aspects.
    Papadopoulos G; Delakas D; Nakopoulou L; Kassimatis T
    Eur J Cancer; 2011 Apr; 47(6):819-30. PubMed ID: 21354784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in oncological research: from experimental studies to clinical practice.
    Kubatka P; Kruzliak P; Rotrekl V; Jelinkova S; Mladosievicova B
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):296-311. PubMed ID: 25220658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho GTPases, statins, and nitric oxide.
    Rikitake Y; Liao JK
    Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.